Becton Dickinson (BDX) Reports In-Line Q4 EPS; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Becton Dickinson (BDX) slumps after guidance disappoints investors
November 9, 2023 12:02 PM ESTShares of medical device maker Becton Dickinson (NYSE: BDX) declined Thursday after it reported quarterly results, along with guidance for 2024. Its outlook was viewed was well below Wall Street expectations and a disappointment to investors.
Becton Dickinson reported earnings per share for its fourth quarter that were in-line with consensus at $3.42. Revenue was slightly better than expected, coming in at $5.1 billion, compared to the consensus of $5.02... More
